|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH AND PRACTICE |
At the time of the study, the authors were with the Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
Correspondence: Requests for reprints should be sent to Rosemarie G. Ramos, PhD, NIH/NIEHS Health Disparities Fellow, MD-NH-04, NH 278, PO Box 12233, Research Triangle Park, NC 27709 (e-mail: ramosr{at}niehs.nih.gov).
Objectives. We sought to determine whether the prevalence of metabolic syndrome among US women of childbearing age (18–44 years) has increased since 1988 and to estimate its current prevalence by race/ethnicity and risk that a maternal history of select metabolic syndrome characteristics imposes on offspring.
Methods. We used survey-specific data analysis methods to examine data from the National Health and Nutrition Examination Surveys conducted from 1988 to 2004.
Results. The prevalence of the metabolic syndrome phenotype and 2 of its clinical correlates significantly increased between 1988 and 2004 (increase for metabolic syndrome phenotype=7.6%, for obesity=13.3%, and for elevated C-reactive protein=10.6%; P<.001 for all 3). Hispanic women were more likely than were White women to possess the phenotype (P= .004). Women who reported that their mothers had been diagnosed with diabetes were more likely to possess the phenotype than those whose mothers had not been so diagnosed (odds ratio=1.9; 95% confidence interval=1.3, 2.8).
Conclusions. The current trends of metabolic syndrome among women of childbearing age demonstrate the need for additional rigorous investigations regarding its long-term effects in these women and their offspring.
Read all eLetters
eLetters:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |